Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 2021 Jan 26;124(9):1612. doi: 10.1038/s41416-020-01242-4

Correction: Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer

Amila Suraweera 1,2,, Alex Duff 1, Mark N Adams 1,2, Christian Jekimovs 1, Pascal H G Duijf 1,3, Cheng Liu 4,5,6, Matthew McTaggart 1, Sam Beard 1, Kenneth J O’Byrne 1,2, Derek J Richard 1,2,
PMCID: PMC8076266  PMID: 33500542

Correction to: British Journal of Cancer (2020) 123, 591–603; 10.1038/s41416-020-0899-2, published online 22 May 2020

Since the publication of this paper, the authors have noticed an error in the name of Kenneth J. O’Byrne, where Dr. O’Byrne’s name was incorrectly listed as Kenneth J. O’ Byrne. This has been corrected above. The original article has been corrected.

Contributor Information

Amila Suraweera, Email: amila.suraweera@qut.edu.au.

Derek J. Richard, Email: derek.richard@qut.edu.au


Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES